BR9911211A - Método para indução de apoptose em células - Google Patents

Método para indução de apoptose em células

Info

Publication number
BR9911211A
BR9911211A BR9911211-6A BR9911211A BR9911211A BR 9911211 A BR9911211 A BR 9911211A BR 9911211 A BR9911211 A BR 9911211A BR 9911211 A BR9911211 A BR 9911211A
Authority
BR
Brazil
Prior art keywords
cells
inducing apoptosis
gene
overexpressed
instance
Prior art date
Application number
BR9911211-6A
Other languages
English (en)
Inventor
Karsten Rothbarth
Hermann Stammer
Dieter Werner
Peter Nehls
Original Assignee
Deustches Krebsforschungszentr
Peter Nehls
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deustches Krebsforschungszentr, Peter Nehls filed Critical Deustches Krebsforschungszentr
Publication of BR9911211A publication Critical patent/BR9911211A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"MéTODO PARA INDUçãO DE APOPTOSE EM CéLULAS". A presente invenção refere-se a um método para acionamento de apoptose, onde o gene C1D é super expresso nas células, de modo particular, em células tumorais. Isto ocorre, por exemplo, através da introdução de correspondentes constructos de expressão nas células ou através da estimulação exógena da expressão dos genes C1D da própria célula.
BR9911211-6A 1998-06-03 1999-06-02 Método para indução de apoptose em células BR9911211A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19824811A DE19824811C2 (de) 1998-06-03 1998-06-03 Verfahren zur Auslösung von Apoptose in Zellen
PCT/DE1999/001684 WO1999063071A2 (de) 1998-06-03 1999-06-02 Verfahren zur auslösung von apoptose in zellen

Publications (1)

Publication Number Publication Date
BR9911211A true BR9911211A (pt) 2002-06-11

Family

ID=7869786

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911211-6A BR9911211A (pt) 1998-06-03 1999-06-02 Método para indução de apoptose em células

Country Status (9)

Country Link
EP (1) EP1121426B1 (pt)
JP (1) JP2002517192A (pt)
CN (1) CN1320163A (pt)
AT (1) ATE264387T1 (pt)
AU (1) AU754686B2 (pt)
BR (1) BR9911211A (pt)
CA (1) CA2330227A1 (pt)
DE (2) DE19824811C2 (pt)
WO (1) WO1999063071A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002042322A2 (en) * 2000-11-21 2002-05-30 Lion Bioscience Ag Mammalian nuclear receptor cofactors cf7 and cf8 and methods of use
DE10225394A1 (de) * 2002-06-07 2003-12-24 Deutsches Krebsforsch Verfahren zur Auslösung von Apoptose in Zellen durch Erhöhung des C1D-Spiegels und Hemmung des Abbaus von C1D

Also Published As

Publication number Publication date
DE19824811C2 (de) 2000-10-12
DE19824811A1 (de) 1999-12-09
WO1999063071A3 (de) 2001-06-07
CA2330227A1 (en) 1999-12-09
AU754686B2 (en) 2002-11-21
DE59909197D1 (de) 2004-05-19
ATE264387T1 (de) 2004-04-15
CN1320163A (zh) 2001-10-31
EP1121426A2 (de) 2001-08-08
AU5152899A (en) 1999-12-20
WO1999063071A2 (de) 1999-12-09
EP1121426B1 (de) 2004-04-14
JP2002517192A (ja) 2002-06-18

Similar Documents

Publication Publication Date Title
EP1507005A3 (en) Antisense modulation of BCL-X expression
IL112539A0 (en) Pyrimidine derivatives and their preparation
EP1117672A4 (en) ANTISENSE MODULATION OF THE SURVIVIN EXPRESSION
MXPA01010588A (es) Medicamentos que contienen de la cinasa humana regulada por el volumen celular h-sgk.
MX9801264A (es) Control de la expresion del gen de cd44 para uso terapeutico.
EP1123414A4 (en) ANTISENSE MODULATION OF THE EXPRESSION OF INTEGRIN ALPHA 4
ATE275956T1 (de) Veränderung der dns methyltransferase durch kombinationstherapie
WO2003083080A3 (en) Mixed- cell gene therapy
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
BR0008788A (pt) Sequencias anti-sentido antitumor dirigidas contra componentes r1 e r2 de ribonucleotìdeo reductase
AU7548500A (en) Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents
ES2187648T3 (es) Metodo para la administracion de farmacos para terapia genica.
GB9825096D0 (en) Cells,culture methods and their uses
WO2003105755A3 (en) ANTISENSE MODULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) EXPRESSION
WO2003104397A3 (en) ANTISENSE MODULATION OF PROTEIN KINASE GR 6 EXPRESSION
TR200101693T2 (tr) Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi.
BR9911211A (pt) Método para indução de apoptose em células
WO2004003152A3 (en) Sos1 inhibitors
AU2606000A (en) Antisense modulation of x-linked inhibitor of apoptosis expression
BR0313550A (pt) modulação "antisense" da expressão de sintetase 1 de acil-coa
PT1064265E (pt) Sintese de 3-amino-2-cloro-4-metilpiridina a partir de malononitrilo e acetona
WO2003062197A3 (en) Nek2 inhibitors
WO2003106645A3 (en) ANTISENSE MODULATION OF SMRT COREPRESSOR EXPRESSION
WO2003105754A3 (en) ANTISENSE MODULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR B (VEGF-B) EXPRESSION
DE69840986D1 (de) DNA Fragmente die das Biotin Synthasegen enthalten und deren Verwendung

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5,6,7 E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.